|LETTER TO EDITOR
|Year : 2020 | Volume
| Issue : 6 | Page : 299-300
Analgesia/Nociception Index May Not Be an Ideal Surrogate Postoperative Pain Measurement Tool for Burn Injury Patients Undergoing Propofol-Based General Anesthesia
Meng-Fu Lai1, Yi-Hsuan Huang1, Hou-Chuan Lai1, Zhi-Fu Wu2
1 Department of Anesthesiology, Tri-Service General Hospital and National Defense Medical Center, Taipei, Taiwan
2 Department of Anesthesiology, Tri-Service General Hospital and National Defense Medical Center, Taipei; Department of Anesthesiology, Chi Mei Medical Center, Tainan City; Department of Anesthesiology, Kaohsiung Medical University Chung Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
|Date of Submission||01-Jul-2020|
|Date of Decision||20-Jul-2020|
|Date of Acceptance||11-Aug-2020|
|Date of Web Publication||12-Sep-2020|
Dr. Zhi-Fu Wu
No. 901, Zhonghua Rd., Yongkang Dist., Tainan City 71004
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Lai MF, Huang YH, Lai HC, Wu ZF. Analgesia/Nociception Index May Not Be an Ideal Surrogate Postoperative Pain Measurement Tool for Burn Injury Patients Undergoing Propofol-Based General Anesthesia. J Med Sci 2020;40:299-300
|How to cite this URL:|
Lai MF, Huang YH, Lai HC, Wu ZF. Analgesia/Nociception Index May Not Be an Ideal Surrogate Postoperative Pain Measurement Tool for Burn Injury Patients Undergoing Propofol-Based General Anesthesia. J Med Sci [serial online] 2020 [cited 2020 Dec 1];40:299-300. Available from: https://www.jmedscindmc.com/text.asp?2020/40/6/299/294944
The analgesia/nociception index (ANI) is suitable for excluding severe pain because it is associated with a high negative predictive value, and it is commonly used in clinical anesthesia., In addition, Boselli et al. reported that ANI is a reliable modality for evaluating immediate postoperative pain. Herein, we present two cases for which ANI was used in the postanesthesia care unit (PACU) for postoperative pain assessment with totally reciprocal representations.
Case 1 was that of a 20-year-old male with second-degree burns on the lower legs involving about 38% total body surface area (TBSA) due to a boiler explosion, who underwent total intravenous anesthesia (TIVA) using propofol and remifentanil for debridement. He complained of severe pain (numeric pain rating scale [NRS] 10/10) when arriving at the PACU, and ketamine 50 mg was administered. Four days later, he underwent the same procedure under TIVA with an identical regimen. He complained of an excruciating pain (NRS 10/10) on arriving at the PACU again, and the ANI value was 67–70.
Case 2 was that of a 69-year-old female who underwent TIVA for second-degree scald injury (about total 6% TBSA) wound debridement and split-thickness skin grafting in the lower legs. ANI was monitored after deep removal of laryngeal mask airway on arrival to the PACU. Severe pain intensity was rated (NRS 8/10) at a very clear consciousness level during transportation to the PACU, and the ANI values reached 99 on arrival [Figure 1].
|Figure 1: The analgesia/nociception index value reaches 99 while the patient complained of severe pain (numeric pain rating scale 8/10) in the postanesthesia care unit|
Click here to view
These two cases show that ANI value does not reflect clinical reality in the PACU accurately after propofol-based TIVA. This distinct phenomenon might be explained by the findings of the study by Joo et al.; they suggested that autonomic nervous system dysfunction interferes with pain threshold in patients with burns. Burn patients are exposed to a sympathetic predominance and decreased parasympathetic activity in circadian rhythm, which possibly decrease the pain threshold and increase pain sensitivity. Aside from the decreasing subjective pain threshold, ANI value is calculated from heart rate variability and correlated with parasympathetic predominance, which is in contrast to what is observed in burn patients. In addition, burn-related pain is complex and involves many factors, including esthetic appearance, social relationships, and physical and psychological function, and, therefore, it is notoriously difficult to measure. Repetitive debridement and daily wound care throughout the healing process may arouse anxiety and emotional distress, which progress over time and cause long-term pain management problems. In addition, opioid analgesia remains the mainstay of pain treatment in burn patients, which makes tolerance issue highly possible after prolonged exposure. For postoperative analgesia, these two cases received intravenous tramadol every 8 h and parecoxib in 12-h interval. Moreover, remifentanil-induced hyperalgesia should be considered although gradual withdrawal modality was applied.
Although ANI performed significantly better in those undergoing propofol-based TIVA compared with those receiving halogenated agents, longer duration of exposure to halogenated agents may blunt ANI accuracy, and ANI is suitable for excluding severe pain because it is associated with a high negative predictive value., The two cases presented herein show that for burn patients undergoing TIVA with propofol and remifentanil, ANI may not be an ideal evaluation tool for postoperative pain accurately in the PACU. Therefore, the accuracy of ANI for acute postoperative pain after different anesthetics is still controversial, hence further investigation is needed to corroborate our observation.
The patients' consent for publication was obtained.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patients have given their consent for their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published, and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Ledowski T, Tiong WS, Lee C, Wong B, Fiori T, Parker N. Analgesia nociception index: Evaluation as a new parameter for acute postoperative pain. Br J Anaesth 2013;111:627-9.
Boselli E, Jeanne M. Analgesia/nociception index for the assessment of acute postoperative pain. Br J Anaesth 2014;112:936-7.
Chen SY, Wu ZF, Yang MT, Lai HC, Hung NK. Is analgesia nociception index monitor suitable for post-heart transplant patients under general anesthesia? J Med Sci. DOI: 10.4103/jmedsci.jmedsci_197_19.
Boselli E, Daniela-Ionescu M, Bégou G, Bouvet L, Dabouz R, Magnin C, et al
. Prospective observational study of the noninvasive assessment of immediate postoperative pain using the analgesia/nociception index (ANI). Br J Anaesth 2013;111:453-9.
Wu TS, Wu HC, Wu ZF, Huang YH. Nalbuphine sebacate interferes with theanalgesic effect of fentanyl. J Med Sci 2020;40:101-2. [Full text]
Joo SY, Hong AR, Lee BC, Choi JH, Seo CH. Autonomic nerve activity indexed using 24-h heart rate variability in patients with burns. Burns 2018;44:834-40.
Luo J, Min S. Postoperative pain management in the postanaesthesia care unit: An update. J Pain Res 2017;10:2687-98.
Yuxiang L, Lingjun Z, Lu T, Mengjie L, Xing M, Fengping S, et al
. Burn patients' experience of pain management: A qualitative study. Burns 2012;38:180-6.